Inmunidad de las Mucosas y Alergia: de la Inmunopatología a la Terapia.
![Foto de Inmunidad de las Mucosas y Alergia: de la Inmunopatología a la Terapia.](/img/uploaded/21C42DF6CDA0E8472C44DA6D4C40ABE3.png)
![Foto de Institut d'Investigacions Biomèdiques August Pi i Sunyer](/img/noimage_org.png)
Institut d'Investigacions Biomèdiques August Pi i Sunyer
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Institut d'Investigacions Biomèdiques August Pi i Sunyer (8)
2024
-
Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA
Pharmaceutics, Vol. 16, Núm. 5
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Genetic Architecture of Ischaemic Strokes after COVID-19 Shows Similarities with Large Vessel Strokes
International Journal of Molecular Sciences, Vol. 24, Núm. 17
2022
-
A first update on mapping the human genetic architecture of COVID-19
Nature
-
Novel genes and sex differences in COVID-19 severity
Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806
-
Whole-genome sequencing reveals host factors underlying critical COVID-19
Nature, Vol. 607, Núm. 7917, pp. 97-103
2021
-
Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality
Journal of Clinical Investigation, Vol. 131, Núm. 23
-
Growth arrest-specific factor 6 (Gas6) is increased in covid-19 patients and predicts clinical outcome
Biomedicines, Vol. 9, Núm. 4